N/A N=49 Randomized Quadruple-blind Treatment

Treatment of Androgenetic Alopecia in Males

Androgenetic Alopecia · Hair Loss · Male Pattern Baldness

Bottom Line

View on ClinicalTrials.gov: NCT00947505 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2012

Primary outcome: Primary: Changes in Terminal Hair Count at 16 and 26 Weeks Over Baseline — 17.7; 2.8; 18.4; 1.6 change in terminal hair count

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: HairMax LaserComb 2009, 7 Beam (Device); HairMax LaserComb (Device)
Age: Adult · 25+ yrs
Sex: Male
Sponsor: Lexington International, LLC
Primary completion: Aug 2010

Outcome Measures

Outcome	Result	p-value
PRIMARY Changes in Terminal Hair Count at 16 and 26 Weeks Over Baseline	17.7; 2.8; 18.4; 1.6	—

Summary

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 7 Beam model in promoting hair growth in males diagnosed with androgenetic alopecia when treatment is applied as directed.

Eligibility Criteria

Inclusion Criteria

Diagnosis of androgenetic alopecia
Fitzpatrick Skin Types I-IV
Norwood-Hamilton IIa to V
Active hair loss within last 12 months

Exclusion Criteria

Photosensitivity to laser light
Malignancy in the target area

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00947505). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.